REY-GIRAUD AGNES 4

What Happened Agnes Rey-Giraud, a director of GoodRx Holdings, exercised stock options on March 12, 2026 to acquire 192,185 shares of Class A common stock at $0.47 per share for a total cash outlay of $90,327. On the same date she transferred 75,219 shares to the Agnes Rey-Giraud Trust; the filing lists this transfer as a gift, and she is the trust’s sole trustee and sole beneficiary.

Key Details

• Transaction date: March 12, 2026; Form 4 filed March 13, 2026 (timely).
• Option exercise: 192,185 shares acquired at $0.47 each, total $90,327. The option is fully vested and exercisable (Footnote F2).
• Transfers: 75,219 shares transferred to the Agnes Rey-Giraud Trust (reported as a gift); filing notes she is the sole trustee and sole beneficiary (Footnote F1).
• The filing also shows a derivative disposition entry for 192,185 shares at $0.00 (reported as a derivative disposition in the Form 4).
• Shares owned after the transaction: not specified in the filing.

Context

• The M-code entries indicate an option exercise (acquisition). There is no open-market sale reported in this filing. Purchases or option exercises represent an insider acquiring stock, which some investors view as more informative than gifts or routine transfers.
• The reported transfer to a trust is an intra-personal transfer (she remains beneficiary/trustee) and should not be interpreted as a market sale. Gift (G) entries generally do not signal investment intent.